Alignment Healthcare, Inc. (ALHC) — SEC Filings
Alignment Healthcare, Inc. (ALHC) — 44 SEC filings. Latest: 10-Q (Apr 30, 2026). Includes 20 8-K, 7 10-Q, 4 4.
View Alignment Healthcare, Inc. on SEC EDGAR
Overview
Alignment Healthcare, Inc. (ALHC) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Apr 30, 2026: Alignment Healthcare, Inc. filed its quarterly report (10-Q) on April 30, 2026, for the period ending March 31, 2026. The filing includes financial statements and other disclosures relevant to the company's performance. The company's mailing and business address is 1100 W. Town and Country Road, Sui
Sentiment Summary
Across 44 filings, the sentiment breakdown is: 2 bullish, 1 bearish, 41 neutral. The dominant filing sentiment for Alignment Healthcare, Inc. is neutral.
Filing Type Overview
Alignment Healthcare, Inc. (ALHC) has filed 4 4, 1 144, 7 10-Q, 20 8-K, 2 DEF 14A, 2 10-K, 4 SC 13G/A, 3 SC 13G, 1 DEFA14A with the SEC between Jan 2024 to Apr 2026.
Filings by Year
Recent SEC Filings (44)
Risk Profile
Risk Assessment: Of ALHC's 34 recent filings, 1 were flagged as high-risk, 11 as medium-risk, and 22 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $993,695 thousand |
| Net Income | $3,729 thousand |
| EPS | N/A |
| Debt-to-Equity | 2.00 |
| Cash Position | $618,067 thousand |
| Operating Margin | 0.8% |
| Total Assets | $1,102,614 thousand |
| Total Debt | $322,736 thousand |
Key Executives
- John E. Kao
- 0001222028
- Christopher Joyce
- 0001032563
- Dr. David L. S. Ting
- Ms. Jennifer L. Thornton
- Ms. Sarah M. Johnson
- David L. S. Ting
- Dr. David S. Chen
- Ms. Sarah E. Johnson
- Mr. Thomas G. MacGregor
- Mr. Stephen F. F. L. Nelson
- Dr. David M. Sabgir
- Abigail P. Johnson
Industry Context
The health insurance industry, particularly Medicare Advantage, is characterized by intense competition and evolving regulatory landscapes. Companies like Alignment Healthcare operate within a framework heavily influenced by government programs like CMS, requiring constant adaptation to reimbursement policies and member needs. Growth is often driven by expanding member enrollment and managing medical costs effectively.
Top Tags
financial-reporting (8) · healthcare (6) · sec-filing (6) · 10-Q (5) · corporate-governance (5) · insider-filing (3) · financials (3) · Alignment Healthcare (3) · quarterly-report (2) · ownership-change (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net income | $3,729 thousand | for the three months ended September 30, 2025, a swing from a $26,429 thousand net loss in 2024 |
| Total revenues | $993,695 thousand | for the three months ended September 30, 2025, up from $692,433 thousand in 2024 |
| Earned premiums | $983,681 thousand | for the three months ended September 30, 2025, a primary driver of revenue growth |
| Medical expenses | $868,022 thousand | for the three months ended September 30, 2025, reflecting increased member utilization |
| Cash and cash equivalents | $618,067 thousand | as of September 30, 2025, a significant increase from $432,859 thousand at December 31, 2024 |
| Net cash provided by operating activities | $190,302 thousand | for the nine months ended September 30, 2025, indicating strong cash generation |
| Accumulated deficit | $998,011 thousand | as of September 30, 2025, still substantial despite recent profitability |
| Shares of common stock outstanding | 200,091,742 | as of October 27, 2025 |
| Net Loss | $309M | for the six months ended June 30, 2025, indicating significant financial deterioration. |
| Period End Date | 2025-06-30 | The end of the reporting period for the 10-Q filing. |
| Period Start Date | 2025-01-01 | Start of the reporting quarter |
| Prior Year End Date | 2024-12-31 | Previous balance sheet date for comparison |
| Reporting Period for Equity Awards | 2021-2024 | Covers multiple fiscal years for granted and outstanding equity awards. |
| Acquisition Price Per Share | $18.00 | Cash consideration offered by UnitedHealth Group to acquire Alignment Healthcare. |
| Fiscal Year | 2024 | Reporting period for the 10-K |
Forward-Looking Statements
- {"claim":"FMR LLC will maintain a significant, but potentially fluctuating, stake in Alignment Healthcare, Inc. over the next year.","entity":"FMR LLC","targetDate":"2025-02-09","confidence":"medium"}
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Alignment Healthcare, Inc. (ALHC)?
Alignment Healthcare, Inc. has 44 recent SEC filings from Jan 2024 to Apr 2026, including 20 8-K, 7 10-Q, 4 4. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of ALHC filings?
Across 44 filings, the sentiment breakdown is: 2 bullish, 1 bearish, 41 neutral. The dominant sentiment is neutral.
Where can I find Alignment Healthcare, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Alignment Healthcare, Inc. (ALHC) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Alignment Healthcare, Inc.?
Key financial highlights from Alignment Healthcare, Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for ALHC?
The investment thesis for ALHC includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Alignment Healthcare, Inc.?
Key executives identified across Alignment Healthcare, Inc.'s filings include John E. Kao, 0001222028, Christopher Joyce, 0001032563, Dr. David L. S. Ting and 9 others.
What are the main risk factors for Alignment Healthcare, Inc. stock?
Of ALHC's 34 assessed filings, 1 were flagged high-risk, 11 medium-risk, and 22 low-risk.
What are recent predictions and forward guidance from Alignment Healthcare, Inc.?
Recent forward-looking statements from Alignment Healthcare, Inc. include guidance on {"claim":"FMR LLC will maintain a significant, but potentially fluctuating, stake in Alignment Healthcare, Inc. over the.